companydata.dkcompanydata.dk

PHARMA MEDICO ApS: Financial statements 2023

CVR: 28665741

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

PHARMA MEDICO ApS (CVR 28665741) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 26,192,940 and a net result of DKK 14,018,627 compared with DKK 16,438,049 the year before. That is a decrease of 13.6% compared with the year before. Equity in the 2023 report amounted to DKK 59,529,489. The solvency ratio was 82.7%. The company had 9 employees in the financial year.

Gross Profit
DKK 26,192,940
Profit/Loss
DKK 14,018,627
Equity
DKK 59,529,489
Total Assets
DKK 71,957,572
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-26.2 mio.14 mio.59.5 mio.9
2022-30.3 mio.16.4 mio.51.5 mio.9
2021-19.2 mio.10.4 mio.39.6 mio.10
2020-10.7 mio.2 mio.29.2 mio.10
2019-13.7 mio.4.8 mio.27.2 mio.11

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

PHARMA MEDICO ApS: The 2022 annual report is outJun 22, 2023

PHARMA MEDICO ApS has published its annual report for 2022. Gross profit came to DKK 30,301,123, and the net result was DKK 16,438,049.

About PHARMA MEDICO ApS

PHARMA MEDICO ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named PHARMA MEDICO US ApS. The management consists of Morten Christensen. The company is owned by G.WAVE ApS and Pharma Medico UK Limited. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 32,265,731 and a net result of DKK 15,407,736 compared with DKK 8,608,967 the year before. Equity in the 2025 report amounted to DKK 63,546,192.

Source: annual report 2025, Danish Business Authority